What do we want from global health in 2018? The Lancet's editor-in-chief Richard Horton discusses his hopes for world health, as well as looking back at 2017.

Adam Bemma discusses his world report on the Rohingya refugees' attempts to settle in Malaysia.

Rebecca Cooney discusses the newly FDA-approved gene therapy for treating loss of vision as a result of retinal dystrophy.

The author of the Wakley Prize-winning essay, Kate Rowland, talks about the ethics of care and the philosophy underlying the clinician-patient relationship, themes raised in her essay.

Joan Marsh and Paul Glasziou discuss what steps can be taken to reduce research waste with the public availability of trial protocols.

Roy Taylor talks about weight management techniques and remission in type 2 diabetes.

Martin McKee discusses the final report of the Lancet's Commission on liver disease, highlighting the health costs of excess alcohol consumption, obesity, and viral hepatitis.

Kazem Rahimi discusses the temporal trends and patterns in heart failure incidence in the UK between 2002 and 2014. 

Nick Watts and Elizabeth Robinson discuss their findings from the 2017 report of The Lancet Countdown: Tracking Progress on Health and Climate Change

Joe Parkin Daniels, author of a new World Report on a military hospital in Bogota, joins us to discuss the nuances of peace and conflict in Colombia since the FARC peace deal, and the challenges still facing healthcare in the country.